Doctors Are Using A New Method Of Treatment Of Peyronie's Disease.
The basic stimulant treatment for unusual curvature of the penis has been approved by the US Food and Drug Administration, the action announced Friday Dec 2013. Men with the condition, called Peyronie's disease, have a hunk in the penis that causes curvature of at least 30 degrees during an erection. The disorder, which is caused by blemish tissue under the skin of the penis, can cause bothersome symptoms during sex.
Until now, surgery was the only medical way out for men with the condition, according to an FDA bulletin release. The FDA's approval of the drug Xiaflex (collagenase clostridium histolyticum) to aide men with Peyronie's disease calls for a maximum of four treatment cycles. Each pattern consists of two injections and one penile remodeling procedure performed by a health care professional. The licence is based on two studies involving more than 800 men with Peyronie's disease.
Showing posts with label penis. Show all posts
Showing posts with label penis. Show all posts
Wednesday, 13 December 2017
Sunday, 15 December 2013
In Men With Prostate Cancer Observed Decrease In Penis Size
In Men With Prostate Cancer Observed Decrease In Penis Size.
A flat million of men with prostate cancer complain that their penis appears to be shorter following treatment, doctors report. According to researchers from the Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, these patients said that this unexpected ancillary implication interfered with their insinuate relationships and made them regret the type of treatment they had chosen. "Prostate cancer is one of the few cancers where patients have a exquisite of therapies, and because of the range of possible side effects, it can be a tough choice," mull over leader Dr Paul Nguyen, a radiation oncologist, said in a Dana-Farber news release.
So "This workroom says that when penile shortening does occur, it really does affect patients and their nobility of life. It's something we should be discussing up front so that it will help reduce treatment regrets". The cause effect was most common among men who had prostatectomies, which is the surgical removal of the prostate, and those who had hormone-based remedy coupled with radiation. Nguyen added that most patients are able to cope with just about any side effect if they remember about it in advance.
The study involved 948 men with recurrent prostate cancer. The men were enrolled in a registry that collects message on patients whose prostate cancer shows signs of coming back after their primary treatment. Most of the men were between the ages of 60 and 80. Of the men snarled in the study, 54 percent had their prostate surgically removed, 24 percent received dispersal combined with hormone-blocking treatment and 22 percent chose to undergo only radiation.
A flat million of men with prostate cancer complain that their penis appears to be shorter following treatment, doctors report. According to researchers from the Dana-Farber Cancer Institute and Brigham and Women's Cancer Center, Boston, these patients said that this unexpected ancillary implication interfered with their insinuate relationships and made them regret the type of treatment they had chosen. "Prostate cancer is one of the few cancers where patients have a exquisite of therapies, and because of the range of possible side effects, it can be a tough choice," mull over leader Dr Paul Nguyen, a radiation oncologist, said in a Dana-Farber news release.
So "This workroom says that when penile shortening does occur, it really does affect patients and their nobility of life. It's something we should be discussing up front so that it will help reduce treatment regrets". The cause effect was most common among men who had prostatectomies, which is the surgical removal of the prostate, and those who had hormone-based remedy coupled with radiation. Nguyen added that most patients are able to cope with just about any side effect if they remember about it in advance.
The study involved 948 men with recurrent prostate cancer. The men were enrolled in a registry that collects message on patients whose prostate cancer shows signs of coming back after their primary treatment. Most of the men were between the ages of 60 and 80. Of the men snarled in the study, 54 percent had their prostate surgically removed, 24 percent received dispersal combined with hormone-blocking treatment and 22 percent chose to undergo only radiation.
Subscribe to:
Posts (Atom)